Chandan Healthcare Limited Share Price & Stock Analysis

Chandan Healthcare Limited (NSE: CHANDAN) is a Lucknow, Uttar Pradesh-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹582 Cr, it ranks #1,918 by market cap among the 6,197 Indian listed companies on FinBizNet, and #8 of 18 in Medical Diagnostic Centres. At ₹236.00 (as of 16 Nov 2026), the share price is 0.0% below its 52-week high of ₹236.00 and 2.6% above its 52-week low of ₹230.00.

Key Metrics

Current Price₹236.00
Market Cap₹582 Cr
NSE SymbolCHANDAN
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Services > Medical Diagnostic Centres
P/E Ratio21.9
Return on Equity18.43%
Return on Assets10.74%
52-Week Range₹230.00 – ₹236.00
Beta (1Y)0.1
Dividend Yield0.00%
HeadquartersLucknow, Uttar Pradesh
Websitewww.chandandiagnostic.com

Latest Quarterly Results — Q1 FY27

Revenue₹81 Cr
Net Profit₹8 Cr
Net Margin9.8%
EPS (Basic)₹3.07
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Shareholding and Delivery

Promoters held 48.43% of Chandan Healthcare Limited's shares as of Sept 2026, against 49.47% in Sept 2025 (−1.04 percentage points).

About Chandan Healthcare Limited

Chandan Healthcare Limited operates laboratories in India. The company offers pathology services, such as biochemistry, hematology, histopathology, microbiology, and immunology tests, as well as radiology services, including x-rays, ultrasonography, computed tomography (CT) scan, and magnetic resonance imaging services. The company also provides healthcare and diagnostic services. The company was incorporated in 2003 and is based in Lucknow, India.

Products and Services

1. Diagnostics Services-This segment operates state-of-the-art laboratories that provides pathological investigations and radiology services. 2. NA-NA 3. NA-NA 4. NA-NA

Chandan Healthcare Limited vs Peers — Medical Diagnostic Centres

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Dr. Lal Pathlabs Ltd₹33,934 Cr66.421.48%₹874 Cr+28.7%
Vijaya Diagnostic Centre Limited₹14,665 Cr84.319.70%₹255 Cr+38.5%
Metropolis Healthcare Limited₹11,952 Cr61.513.37%₹497 Cr+14.9%
Throcare Technologies Ltd₹7,764 Cr47.628.74%₹271 Cr+7.5%
SURAKSHA DIAGNOSTIC LIMITED₹1,856 Cr55.413.84%₹99 Cr+6.9%
Krsnaa Diagnostics Ltd₹1,625 Cr16.810.89%₹271 Cr-27.0%
Gaudium IVF and Women Health Limited₹803 Cr27.416.08%₹37 Cr—
Chandan Healthcare Limited₹582 Cr21.918.43%₹81 Cr—
Aspira Pathlab & Diagnostics Ltd₹127 Cr2,360——+115.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Chandan Healthcare Limited?

Chandan Healthcare Limited is trading at ₹236.00, with a market capitalisation of ₹582 Cr.

Which sector does Chandan Healthcare Limited belong to?

Chandan Healthcare Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).

What are the key financial ratios of Chandan Healthcare Limited?

Chandan Healthcare Limited has a P/E of 21.9 and a return on equity of 18.43%.

What is the stock symbol of Chandan Healthcare Limited?

Chandan Healthcare Limited is listed on the NSE under the symbol CHANDAN.

What were Chandan Healthcare Limited's latest quarterly results?

In Q1 FY27, Chandan Healthcare Limited reported revenue of ₹81 Cr and net profit of ₹8 Cr, with basic EPS of ₹3.07 (consolidated, parsed from the company's exchange filing).

What is the promoter holding in Chandan Healthcare Limited?

Promoters held 48.43% of Chandan Healthcare Limited's shares as of Sept 2026, against 49.47% in Sept 2025 (−1.04 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.